Dr.ssa Claudia Ferrier-Guerra
Pagina 1
Rev 008 12.02.2016
PERSONAL DETAILS
Family Name
Ferrier-Guerra
Given names
Claudia Paola
Nationality
Swiss
Languages:
Italian (mothertongue), English, French, German
CONTACT
Phone: +41 91 950 91 85
Fax: +41 91 950 91 89
E-Mail: ferrier-guerra@bluewin.ch
DEGREES AND PROFESSIONAL QUALIFICATIONS
Medical degree:
December 16th 1981, University of Berne, Switzerland
M.D. (Thesis):
December 6th 1982, University of Berne, Switzerland
FMH Internal Medicine:
January 3rd 1989 - Title of specialist in (Swiss College
Physicians) internal medicine
FMH Nephrology
(Specialty in nephrology):
January 27th 1993
Higher degree of Doctor of
Medicine
March 9th 1995, University of Melbourne, Australia
Present Position:
Physician in charge Nephrology Clinic and Dialysis Unit,
Clinica Moncucco, Lugano, Switzerland.
Responsible for Quality Management System according
to ISO-9001:2000
Consultant Renal Physician, Clinica Moncucco, Lugano
Consultant, on request, in Obstetric Medicine at the
Women’s Hospital, University of Basel, Switzerland
Responsible for the continuing medical education (CME)
of the Lugano District Medical Association (CML)
From 2011 Master in Management and Healthcare
Organisations (Net-MEGS), University of Lugano, CH
PROFESSIONAL EXPERIENCE
January 1982 – August 1982:
University of Berne, Medizinische Poliklinik,
Research fellow, Hypertension Unit
October 1982 – July 1983:
Clinical Fellow in Respiratory Diseases
Dr.ssa Claudia Ferrier-Guerra
Pagina 2
Rev 008 12.02.2016
Medizinische Klinik, University of Berne.
September 1983 – September 1984:
Clinical Fellow in General Internal Medicine,
Ospedale Italiano, Lugano, Switzerland.
(Dr.Beretta-Piccoli Carlo, Professor at the University of
BerneOctober 1984 – June 1986:
Registrar in Internal
Medicine (incl. Nephrology)
University of
Berne, Medizinische Poliklinik (Prof. Reubi)
July 1986 – August 1986:
Visiting Medical Officer in Radiology and Infectious
Diseases,
St. Vincent Hospital Worchester, MA, USA.
October 1986 – March 1989:
Registrar
in
general
medicine,
and
registrar
in
Nephrology. University of Berne, Medizinische Poliklinik.
April 1989 – January 1991:
Clinical fellow in cardiovascular diseases, hypertension,
and clinical pharmacology. Baker Medical Research
Institute, Melbourne, Australia.
February 1991 – March 1994:
Fellow in nephrology and obstetric medicine, Royal
Melbourne Hospital, University of Melbourne, Victoria,
Australia
(Prof. P. Kincaid-Smith & Prof. G. Becker)
October 1994 – October 1995:
Senior Research Fellow, University of Lausanne.
November 1995- March1997
Consultant physician in Nephrology
Nephrology Division, Inselspital Berne
Consultant-Physician at the Women’s Hospital, University
of Berne, for Renal Disease in Pregnancy.
AWARDS
1988: Research Grant from the “Swiss National Science Foundation”
INVITED LECTURES
CNS noradrenergic function in human hypertension as assessed from internal jugular plasma noradrenaline
and DHPG.
National Institutes of Health, Bethesda, Maryland, USA, November 1991
COMMITEES SERVED ON
Board Member of the “Swiss Italian Medical Association" (OMCT)
President of Lugano District Medical Association (CML)
Board Member "Ticino Sate Ethical Commision”
MEMBERSHIP OF Profesional Associations
1. Swiss Society of Internal Medicine
2. Swiss Society of Nephrology
3. Italian Society of Nephrology
4. International Society of Nephrology
5. Australian & New Zealand Society of Nephrology
6. High Blood Pressure Reseasch Council of Australia
Dr.ssa Claudia Ferrier-Guerra
Pagina 3
Rev 008 12.02.2016
7. International Society for Study of Hypertension in Pregnancy (ISSHP)
8. Australasian Society for Study of Hypertension in Pregnancy (ASSHP)
PUBLICATIONS
1. Ferrier CP, Bianchetti MG, Beretta-Piccoli CF, Link L, Bachmann C, Weidmann P.
Studies on the mechanism of acute glucose-induced aldosterone suppression. Role of corticotropin. Acta
Endocrinol 1983;103:391-399
2. Nuetzi D, Beretta-Piccoli CF, Ferrier CP, Link L, Weidmann P. Studies on acute glucose-induced
aldosterone suppression: Role of renin-angiotensin system. Klin Wochenschr 1984;62:213-217
3. Bianchetti MG, Weidmann P, Beretta-Piccoli C, Rupp U, Boehringer K, Link L, Ferrier C. Disturbed
noradrenergic blood pressure control in normotensive members of hypertensive families. Br Heart J
1984;51:306-311
4. Ferrier CP, Beretta-Piccoli CF, Weidmann P, Mordasini R. Alpha-1-adrenergic blockade and lipoprotein
metabolism in essential hypertension. Clin Pharmacol Ther 1986;40:525-530
5. Beretta-Piccoli CF, Ferrier CP, Weidmann P. Alpha-1-adrenergic blockade and cardiovascular pressor
responses in essential hypertension. Hypertension 1986;8:407-417
6. Bianchetti L, Ferrier, Beretta-Piccoli C, Fraser R, Morton JJ, Ziegler WH. Adrenergic activity and
alosterone regulation: no evidence for alpha-1 adrenoceptor-mediated influence in normal subjects.
Clinical Endrocrinol (Oxf) 1986;25:87-95
7. Bianchetti MG, Beretta-Piccoli CF, Weidmann P, Ferrier C. Blood pressure control in normotensive
members of hypertensive families. Kidney Int 1986;29:882-888
8. Bianchetti MG, Weidmann P, Beretta Piccoli CF, Ferrier C. Potassium and norepinephrine- or
angiotensin-mediated pressor control in pre-hypertension. Kidney Int 1987;31:956-963
9. Ferrier C, Weidmann P, Hollmann R, Dietler R, Shaw S. Impaired response of atrial natriuretic factor to
high salt intake in hypertension-prone man. N Engl J Med 1988;319:1223.1224
10. Ferrier C, Kurtz A, Lehner P, Shaw S, Pusterla C, Saxenhofer H, Weidmann P. Stimulation of renin
secretion by potassium-channel activation with cromakalin. Eur J Clin Pharmacol 1989;36:443-447
11. Ferrier C, Beretta-Piccoli C, Weidmann P, Gnaedinger M, Shaw S, Suchecka-Rachon K, Saxenhofer H.
Hypotension and renal impairment during infusion of atrial natriuretic factor in liver cirrhosis with ascites.
Am J Nephrol 1989;9:921-299
12. Suda S, Weidmann P, Saxenhofer H, Cottier C, Shaw S, Ferrier C. Atrial natriuretic factor in mild to
moderate chronic renal failure. Hypertension 1988;11:483-490
13. Saxenhofer H, Angst, Weidmann P, Shaw S, Ferrier C. Corticosteroid-induced stimulation of atrial
natriuretic peptide in man. Acta Endocrinol 1988;118:179-186
14. Weidmann P, Schohn D, Gnaedinger MP, Buergisser E, Ferrier C, Jahn H. Hypertensive dysregulation
and its modification by calcium channel blockade in chronic non-oliguric renal failure. Am I Nephrol 1989;
9:269-278
15. Uehlinger DE, Ferrier C, Weidmann P, Matthieu R, Reuter K, Gnaedinger M, Saxenhofer H, Shaw S,
Risen W. Antihypertensive contribution of sodium depletion and the sympathetic axis during chronic
angiotensin II converting enzyme inhibition. J. Hypertens 1989;7:901-907
16. Ferrari P, Ferrier C, Franschini L, Saxenhofer H, Shaw S, Weidmann P. Atrial natriuretic factor and
autonomic nervous system function in man. Eur J Clin Pharmacol 1990;38:25-30
Dr.ssa Claudia Ferrier-Guerra
Pagina 4
Rev 008 12.02.2016
17. Ferrari P, Weidmann P, Ferrier C, Dietler R, Hollman R, Shaw S. Dysregulation of atrial natriuretic factor
in hypertension-prone man. J Clin Endocrinol Metab. 1990; 71:944-951
18. Ferrier C, Ferrari P, Weidmann P, Keller U, Beretta-Piccoli C, Riesen W. Efficacy and tolerance of
antihypertensive therapy with the calcium channel blocker verapamil and/or the angiotensin converting
enzyme inhibitor enalapril in diabetic patients. Diabetes Care 1991;14:911-914
19. Eisenhofer G, Meredith I, Ferrier C, Cox E, Lambert G, Jennings G, Esler E. Plasma
dihydroxyphenylalanine (DOPA) is dependent on sympathetic activity in humans. J Lab Clin Med
1991;117:266-273
20. Eisenhofer G, Esler M, Meredith I, Ferrier C, Lambert G, Jennings G. Neuronal re-uptake of
noradrenaline by sympathetic nerves in humans. Clin Sci 1991;80:257-263.
21. Angus J, Ferrier C, Sudhir K, Jennings G. Impaired contraction and relaxation in skin resistance arteries
from patients with congestive heart failure. Cardiovasc Res 1993;27:204-210
22. Saxenhofer H, Morger D, Weidmann P, Ferrier C, Shaw S. Modulation of noradrenergic but not
angiotensinergic blood pressure control by beta-blockade with carteolol. J Hypertens 1991;9:1049-1056
23. Ferrier C, Esler M, Eisenhofer G, Wallin G, Horne M, Cox H, Lamberg G, Jennings G. Increased
norepinephrin spillover into the jugular veins in essential hypertension. Hypertension 1992;19:62-69
24. Wallin G, Esler M, Dorward P, Eisenhofer G, Ferrier C, Westerman R, Jennings G. Simultaneous
measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans.
J Physiol 1992;453:45-58
25. Ferrier C, Cox H, Esler M. Elevated total body noradrenaline spillover in normotensive members of
hypertensive families. Clin Sci 1993;84:225-230
26. Ferrier C, Jennings G, Eisenhofer G, Lambert G, Cox H, Kallf V, Kelly M, Esler M. Evidence for
increased noradrenaline release from subcortical brain regions in essential hypertension. J Hypertens
1993;11:1217-1227
27. Ferrier C, North R, Becker G, Townend K, Kincaid-Smith P. Uterine Artery Waveform Indices in the
second trimester: Resistance Index, Notch measurement and placental position. J Obstet & Gynaecol
1994;14:237-243
28. North R, Ferrier C, Long D, Townend Kkincaid-Smith P. Uterine artery Doppler Flow Velocity Waveform
indices in the second trimester for the prediction of preeclampsia and intrauterine growth retardation.
Obstet Gynaecol 1994;83:378-386
29. Ferrier C, Kincaid-Smith P et al. Doppler ultrasound of uterine arteries for prediction of superimposed
pre-eclampsia in pregnant women with underlying renal disease. Clin Nephrol 1994;42:362-368
30. Ferrier C, Anapalahan M, Becker G, Kincaid-Smith P. Renal vascular changes and uterine artery
resistance in pregnant women with renal disease. Nephron 1994;68:405
31. Esler M, Lambert G, Ferrier C, Kaye D, Wallin G, Kallf M, Kelly M, Jennings G. Central nervous system
noradrenergic control of sympathetic outflow in normotensive and hypertensive humans. Clin Exp
Hypertens 1995; 17:409-423
32. North RA, Ferrier C, Gamble G. Fairley K, Kincaid-Smith P. Prevention of preeclampsia with prophylactic
heparin and anti-platelet agents in women with renal disease. Aust NZ Obstet Gynaecol 1995;35:357362
33. Depairon M, Ferrier CP, Tutta P, Descombes E, van Melle G, Wauters JP. Is ther a place for duplex
screening of brachial artery in haemodialysis patients with vascular access? VASA 2001; 30: 53-58
34. Ferrier C. Ematuria: Approccio Diagnostico. Tribuna Medica Ticinese 2003; 68:5-11
Dr.ssa Claudia Ferrier-Guerra
Pagina 5
Rev 008 12.02.2016
35. Barbey F, Nseir G, Ferrier C, Burnier M, Daudon M. Inhibiteurs de l'anhydrase carbonique et lithiase
urinaire phosphocalcique. Nephrologie 2004; 25: 169-172
36. Casella R, Ferrier C, Giudici G, Dickenmann M, Gianini O, Hoesli I, Bachmann A, Sulser T. Surgical
management of renal cell Carcinoma during the second trimester of pregnancy. Urol Int 2006; 76-180181
37. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Askie LM
et la on behalf of the PARIS COLLABORATIVE GROUP. Lancet 2007
38. Ferrier C, Kürmann P, Antonini P, Belloni F, Vogt N. Lanzoprazole-induced acute renal failure in an older
woman. A case-report, in Press
39. Ferrier-Guerra C, Solcà C. Una strana infezione urinaria. Tribuna Medica Ticinese 2011; 76: 465-467
40. Solcà C. Ferrier-Guerra C. Dialisi negli ultraottantenni? Tribuna Medica Ticinese 2011; 76:463-464
41. Giannini O, Gamondi C, Galli N, Schönholzer C, Marone C, Zwahlen U, Gabutti L, Bianchi G, Ferrier C,
Neuschwander H, Cereghetti C. The DIA-PAIN STUDY: cause, severity and management of pain and
other symptoms in chronic dialysis patients. Submitted
REVIEWS & INVITED BOOK CHAPTERS
1. Ferrier C, Beretta-Piccoli CF, Weidmann P, Bianchetti MG. Different blood pressure responses to
diuretic treatment in normotensive subjects with and without a family history of hypertension. J
Hypertens 1983;1(Suppl 2):31-34
2. Bianchetti MG, Beretta-Piccoli CF, Weidmann P, Link L, Boehringer K, Ferrier C. Calcium and blood
pressure regulation in normal and hypertensive subjects. Hypertension 1983;5 (Suppl 2):57-65
3. Bianchetti MG, Beretta-Piccoli CF, Weidmann P, Ferrier C, Link L, Gerber A. Correction of
cardiovascular hypersensitivity to norepinephrine by potassium supplementation in normotensive
members of hypertensive families and patients
with essential hypertens. J Hypertens 1984;2(Suppl 3):445-448
4. Beretta-Piccoli CF, Ferrier CP, Weidmann P. Cardiovascular effects of short-term selective alpha-1adrenergic blockade with terazosin in patients with essential hypertension. J. Hypertens 1985;3(Suppl
3):S231-S234
5. Gerber A, Weidmann P, Bianchetti MG, Ferrier C, Laederach K, Mordasini R, Riesen W, Bachmann C.
Serum lipoproteins during treatment with the antihypertensive agent indapamide. Hypertension
1985;7(Suppl 2):164-169
6. Weidmann P, Saxenhofer H, Ferrier C, Shaw S. Atrial natriuretic peptide in man. Am J Nephrol 1988;8:114
7. Weidmann P, Ferrier CP, Saxenhofer H, Uehlinger DE, Trost BN. Serum lipoproteins during treatment
with antihypertensive drugs. Drugs 1988;35(Suppl 6):118-23
8. Esler M, Ferrier C, Lambert G, Eisenhofer G, Cox H, Jennings G. Biochemical evidence of sympathetic
hyperreactivity in human hypertension. Hypertension 1991;17(Suppl III):29-35
9. Weidmann P, Ferrari P, Alleman Y, Ferrier C, Shaw S. Developing essential hypertension: A syndrome
involving ANF deficiency? Can J Physiol Pharmacol 1991;69:1582-1591
10. Ferrier C, Ferrari P, Weidmann P, Keller U, Beretta-Piccoli C, Riesen WF. Swiss Hypertension
Treatment Programme with Verapamil and/or Enalapril in Diabetic Patients. Drugs 1992;(Suppl 1):74-84
11. Lambert G, Ferrier C, Kaye D, Cox H, Turner A, Jennings G, Esler M. Monoaminergic neuronal activity in
subcortical brain regions in essetial hypertension. Blood Pressure 1994:55-66
Dr.ssa Claudia Ferrier-Guerra
Pagina 6
Rev 008 12.02.2016
12. Lambert G, Ferrier C, Jennings G, Kallf M, Kelly M, Turner A, Esler M. Central nervous system
norepinephrine turnover un essential hypertension. Ann New York Ac Sci 1995; 763:679-694
13. Ferrier C. Physiopathologie de la preeclampsie: Aspets actuels. Méd Hyg 1995;53:397-400
14. Ferrier C, Wauters JP. Maladies rénales et grossese. Méd Hyg 1995;53:401-405
15. Dürig P, Ferrier C, Schneider H. Hypertensive Schwangerschaftserkrankungen. Therapeutische
Umschau, 1999; 56: 561-567
16. Weidmann P, Saxenhofer H, Ferrier C. Atrial natriuretic peptide in man. In: Functional Morphology of the
Endocrine Heart. Frossmann WG et al eds, Steinkopf Verlag, Darmstadt 1989
17. Saxenhofer H, Cottier C, Suda S, Shaw S, Ferrier CP, Weidmann P. Limited role of right atrial pressure
in the actute control of circulating atrial natriuretic factor. In: American Society of hypertension
Symposium Series, Volume 3. Advances in atrial peptide research. Brenner BM, Laragh JH eds, 1989.
18. Lambert GW, Kaye DM, Thompson JM, Turner AG, Ferrier C, Cox HS, Vaz M, Wilkinson D, Meredith IT,
Jennings GL, Esler MD. Catecholamine metabolites in internal jugular plasma: A window into the human
brain. In: Catecholamines: Bridging Basic Science with Clinical Medicine. Edited by D. Goldstein. Vol. 42
of Advances in Pharmacology, 1997
19. Ferrier C, Gallery E. Pregnancy and therapeutic measures in the patient with diabetic nephropathy. In:
Diabetic Nephropathy. Edited by Geoffrrey Boner & Mark Cooper, 199-206: 2003
20. Roncelli N, Ferrier C, Dürig P, Köferl U, Frey F, Schneider H. Underlying maternal diseases in women
who suffered fron severe preeclampsia and HELLP syndrome. N. Roncelli, MD Thesis, University of
Berne, 18th December 2000
MD THESIS (PD Equivalent)
Ferrier Claudia. Uterine Artery Doppler Ultrasound: Prediction of Pregnancy Outcome in Women with Renal
Disease. Melbourne, 1994.
ABSTRACTS ACCEPTED AND PERSONALLY PRESENTED
Ferrier C, Beretta-Piccoli C, Weidmann P, Mordasini R. Alpha-1-adrenergic blockade and lipoprotein
metabolism in essential hypertension. First International Symposium on Cardiovascular Pharmacotherapy,
Geneva, Switzerland, April 22-26, 1985
Ferrier C, Beretta-Piccoli C, Weidmann P, Gnaedinger M, Shaw S, Suchecka-Tachon K, Saxenhofer H.
Hypotension and renal impairment during infusion of atrial nariuretic factor in liver cirrhosis with ascites.
Annual Meeting of the Swiss Society of Nephrology, Lausanne, Switzerland, December 2-4, 1988
Ferrier C, Hollman R, Dietler R, Shaw S, Weidmann P. Impaired response of atrial nariuretic factor to high
saly intake in hypertension-prone man. 21st Meeting of the American Society of Nephrology, San Antonio,
USA, December 11-14, 1988
Ferrier C, Ferrari P, Weidmann P, Keller U, Riesen W. Renal and metabolic effects of antihypertensive
therapy with verapamil and/or enalapril in patients with diabetes mellitus. 20 th Meeting of the German Society
of Nephrology, Berne, Switzerland, September 17-20, 1989
Dr.ssa Claudia Ferrier-Guerra
Pagina 7
Rev 008 12.02.2016
Ferrier C, Jenning G, Angus J, Dart A. Impaired contraction and relaxation in resistance arteries of patients
with congestive heart failure. 38t h Annual Scientific Meeting of the Cardiac Society of Australia and New
Zealand, Hobart, Australia, May 1990
Ferrier C, Esler M, Jennings G, Eisenhofer G, Lambert G, Cox H, Wallin G, Horne M. Catecholamine
spillover methodology for studying central nervous system turnover in essential hypertension. 13 th Meeting of
the International Society of Hypertension, Montreal, Canada, June 26-29, 1990
Ferrier C, Ferrari P, Weidmann P, Keller U, Riesen W. The Swiss Hypertension Treatment Program in
Diabetes: Antihypertensive effects of verapamil or enalapril in diabetes associated hypertension. Annual
Scientific Meeting of the Australian Diabetes Society, Perth, September 25-27, 1990
Ferrier C, Jennings G, Eisenhofer G, Lambert G, Cox H, Kallf V, Kelly M, Esler M. Evidence for increased
subcortical noradrenaline release in essential hypertensive patients. 14th Meeting of the International Society
of Hypertension. Madrid, Spain, June 15-19, 1992
Ferrier C, Cox H & Esler M. Elevated total body adrenaline spillover in normotensive members of
hypertensive families. 14th Meeting of the International Society of Hypertension, Madrid, Spain, June 15-19,
1992
Ferrier C, North R, Fairley K, Becker G, Dong FP & Kincaid-Smith P. Doppler ultrasound of uterine arteries
for prediction of pregnancy-induced hypertension in women with underlying renal disease. 8 th World
Congress of International Society for the Study of Hypertension in Pregnancy, Buenos Aires, Argentina,
November 8-12, 1992
Ferrier C, Anpalahan M, Becker G, Cincotta R & Kincaid-Smith P. Pre-pregnancy renal vascular changes are
associated with increased uterine artery resistance and predict the development of preeclampsia. 9 th World
Congress of International Society for the Study of Hypertension in Pregnancy. Sydney, Australia, March 1518, 1994
Ferrier C, Taminelli L, Wauters JP. Pregnancy in renal disease. Experience of a single Swiss Center. Annual
Meeting of the Swiss Society of Nephrology, Lausanne, Switzerland, December 7-8, 1995
Ferrier C, North R, Becker G, Kincaid-Smith P. Aspirin does not prevent, but delays the onset of
preeclampsia in pregnancies with increased uteroplacental resistance. 10th World Congress of International
Society for the Study of Hypertension in Pregnancy, Seattle, USA, August, 1996
Ferrier C, Spichtig S, Schneider H, Frey F. Subarachnoidal hemorrhage and ventricular bleeding as first
presentation of severe preeclampsia. A case-report. 10th World Congress of International Society for the
Study of Hypertension in Pregnancy, Seattle, USA, August, 1996
Ferrier C, Pfister M, Montandon A, Frey F. Obstetric Outcome in women with renal transplant: A 15 years
experience. 10th World Congress of International Society for the Study of Hypertension in Pregnancy,
Seattle, USA, August, 1996
Dr.ssa Claudia Ferrier-Guerra
Pagina 8
Rev 008 12.02.2016
Ferrier C, Durig P, Frey F, Schneider H. Severe early-onset preeclampsia and HELLP Syndrome are
associated with underlying essential hypertension. XIV International Congress of Nephrology, Sydney,
Australia, May 25-29 1997
Ferrier C, North R, Becker G, Fairley K, Kincaid-Smith P. Sucessfull pregnancy outcome in women with
reflux nephropathy, normal renal function and uterine artery Doppler. XIV International Congress of
Nephrology, Sydney, Australia, May 25-29 1997
Ferrier C, Köferl U, Dürig P, Schneider H. LMW-heparin and low-dose aspirin for prevention of preeclampsia:
preliminary data of a randomized prospective study. 11th World Congress of International Society for the
Study of Hypertension in Pregnancy, Kobe, Japan, October, 1998
Ferrier C, Köferl U, Dürig P, Schneider H. Effects of LMW-heparin and low-dose Aspirin on renal uric acid
handling in high risk pregnancies. 12th World Congress of the International Society for Study of Hypertension
in Pregnancy. Paris, France, July 2000
Ferrier C, Kürmann P, Antonini P, Belloni F, Vogt N. Acute glomerulonephritis and lanzoprazole therapy: A
possible assosiation. 37th Annual Meeting Australian and New Zealand Society of Nephrology. Darwin 5-7
Sept. 2001
Ferrier C, Giudici G, Dickemann M, Gianini O, Hoesli I, Beck EA, Sulser T. Pregnancy, hypertension,
suspected thrombophilia and renal mass: An unusual case-report. 39th Annual Meeting Australian and New
Zealand Society of Nephrology. Perth 31.8-3 Sept. 2003
Ferrier C, Gallery E, Hösli I, Giudici G, Steiger J. The impact of interdisciplinary follow-up after preeclampsia
in subsequent pregnancy. 42nd Annual Meeting Australian and New Zealand Society of Nephrology.
Melbourne 14-18 August 2006
Ferrier C, Jozefowsky J, Meister G, Hösli I. Premature contractions: an unsual presentation of primary
hyperparathyroidism: A sase Report. International Society of Obstetric Medicine Congress (ISOM).
Melbourne 1-3 October 2010
TEACHING ACTIVITIES
1. MD Thesis Supervision
2.
Clinical teaching
-
Medical students
-
Doctors in nephrology training